| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate |
2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7af27f97a45fa382f5279c78cfbc7612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93b1dd0fa6234913fd869fc23522003 |
| publicationDate |
2018-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201834663-A |
| titleOfInvention |
Dosing regimen for SGLT1/2 inhibitor |
| abstract |
The present invention relates to methods for affecting weight loss, for example in the treatment of obesity and related conditions including those related to and / or caused by obesity itself. |
| priorityDate |
2017-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |